US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CLIMB BIO INC

13.73

-0.8400-5.77%

Post-market: 13.730.00000.00%16:14 EDT

Volume:1.44M

Turnover:19.90M

Market Cap:786.19M

PE:-16.45

High:14.70

Open:14.58

Low:13.49

Close:14.57

52wk High:18.33

52wk Low:1.54

Shares:57.26M

Float Shares:41.60M

Volume Ratio:1.16

T/O Rate:3.45%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.8347

EPS(LYR):-0.8974

ROE:-27.10%

ROA:-18.45%

PB:3.28

PE(LYR):-15.30

Loading ...

Overview Company News Filings

Climb Bio is Maintained at Outperform by Wedbush

Wedbush Raises Price Target on Climb Bio to $20 From $17, Keeps Outperform Rating

MT Newswires Live

Climb Bio Director Breanna Maurine Celebi Files Initial Beneficial Ownership Statement

Climb Bio Names Breanna O’reilly to Board After Andrew Levin Resigns

Climb Bio Price Target Maintained with a $20.00/share by HC Wainwright & Co.

Tango Therapeutics appoints Robert Azelby to board of directors

BRIEF-Climb Bio - Enters Open Market Sale Agreement With Jefferies - SEC Filing

Climb Bio enters Jefferies ATM equity distribution agreement for up to $100 million stock sale

Climb Bio - Enters Open Market Sale Agreement With Jefferies Dated June 12, 2026 - SEC Filing

THOMSON REUTERS

Analysts Conflicted on These Healthcare Names: United Therapeutics (UTHR), DENTSPLY SIRONA (XRAY) and Climb Bio (CLYM)

Climb Bio price target raised to $20 from $19 at BTIG

Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR) and Climb Bio (CLYM)

Climb Bio Is Maintained at Buy by BTIG

Climb Bio reports initial Phase 1b data showing platelet responses for budoprutug in immune thrombocytopenia trial

Climb Bio - Announces Initial Phase 1B Data for Budoprutug in Immune Thrombocytopenia

THOMSON REUTERS

Climb Bio - Enrollment Ongoing in 1000 Mg Cohort With Data Expected by Year-End 2026

THOMSON REUTERS

Climb Bio sets 5,216,105-share cap under 2021 equity incentive plan

Climb Bio initiated with a Buy at Guggenheim

Guggenheim Initiates Climb Bio at Buy With $35 Price Target

MT Newswires Live

Climb Bio Price Target Maintained With a $19.00/Share by BTIG

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/CLYM/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CLYM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLYM\",,,,,undefined,":{"symbol":"CLYM","market":"US","secType":"STK","nameCN":"CLIMB BIO INC","latestPrice":13.73,"timestamp":1788206400000,"preClose":14.57,"halted":0,"volume":1436138,"hourTrading":{"tag":"盘后","latestPrice":13.73,"preClose":13.73,"latestTime":"16:14 EDT","volume":10967,"amount":150579.180169,"timestamp":1788207262093,"change":0,"changeRate":0,"amplitude":0.000728},"delay":0,"changeRate":-0.05765271105010294,"floatShares":41603800,"shares":57260500,"eps":-0.83475,"marketStatus":"Post-Mkt","change":-0.84,"latestTime":"08-31 16:26:34 EDT","open":14.58,"high":14.695,"low":13.4901,"amount":19901872,"amplitude":0.082697,"askPrice":14.5,"askSize":470,"bidPrice":13.5,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-0.83475,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":4,"adr":0,"listingDate":1628222400000,"exchange":"NASDAQ","adjPreClose":14.57,"preHourTrading":{"tag":"盘前","latestPrice":14.35,"preClose":14.57,"latestTime":"09:29 EDT","volume":2351,"amount":34410.81117,"timestamp":1788182998998,"change":-0.22,"changeRate":-0.0151,"amplitude":0.113246},"postHourTrading":{"tag":"盘后","latestPrice":13.73,"preClose":13.73,"latestTime":"16:14 EDT","volume":10967,"amount":150579.180169,"timestamp":1788207262093,"change":0,"changeRate":0,"amplitude":0.000728},"volumeRatio":1.1632,"impliedVol":1.7243,"impliedVolPercentile":0.7124},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLYM\",,,,,undefined,":{"symbol":"CLYM","floatShares":41603800,"roa":"-18.45%","roe":"-27.10%","lyrEps":-0.897422,"volumeRatio":1.1632,"shares":57260500,"dividePrice":0,"high":14.695,"amplitude":0.082697,"preClose":14.57,"low":13.4901,"week52Low":1.54,"pbRate":"3.28","week52High":18.33,"institutionHeld":0,"latestPrice":13.73,"committee":-0.978947,"eps":-0.83475,"divideRate":0,"volume":1436138,"delay":0,"ttmEps":-0.83475,"open":14.58,"prevYearClose":4,"prevWeekClose":14.57,"prevMonthClose":11.9,"prevQuarterClose":13.04,"fiveDayClose":16.4,"twentyDayClose":11.81,"sixtyDayClose":10.91},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CLYM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"CLYM","fiscalQuarterEnding":"2026/06","expectedEps":-0.22,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2026-05-07","symbol":"CLYM","fiscalQuarterEnding":"2026/03","expectedEps":-0.26,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2026-03-05","symbol":"CLYM","fiscalQuarterEnding":"2025/12","expectedEps":-0.2,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2025-11-06","symbol":"CLYM","fiscalQuarterEnding":"2025/09","expectedEps":-0.16,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.19},{"market":"US","date":"2025-08-12","symbol":"CLYM","fiscalQuarterEnding":"2025/06","expectedEps":-0.19,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CLYM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CLYM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5333,"buy":0.4667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5333,"analysts":15,"updateTime":1785816000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CLYM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CLYM","date":"2026-08-28","current":-16.687631,"percent":0.023256,"low":-17.781875,"twenty":-6.894117,"median":-3.079659,"eighty":-1.243636,"high":-0.85032,"avg":-4.641393,"sd":4.128301,"marketCap":864990000},"quantilePoints":[{"date":"2024-10-04","current":-5.327624,"twenty":-5.327624,"median":-5.327624,"eighty":-5.327624,"marketCap":342006831},{"date":"2024-10-11","current":-5.369409,"twenty":-5.463426,"median":-5.390302,"eighty":-5.369409,"marketCap":344689237},{"date":"2024-10-18","current":-5.076912,"twenty":-5.494765,"median":-5.390302,"eighty":-5.327624,"marketCap":325912392},{"date":"2024-10-25","current":-4.85754,"twenty":-5.463426,"median":-5.327624,"eighty":-5.014234,"marketCap":311829757},{"date":"2024-10-31","current":-4.094958,"twenty":-5.404927,"median":-5.238831,"eighty":-4.776059,"marketCap":262875838},{"date":"2024-11-08","current":-3.677105,"twenty":-5.390302,"median":-5.014234,"eighty":-4.074065,"marketCap":236051773},{"date":"2024-11-15","current":-3.107258,"twenty":-5.373588,"median":-4.888879,"eighty":-3.806639,"marketCap":214779913},{"date":"2024-11-22","current":-2.917613,"twenty":-5.335981,"median":-4.293438,"eighty":-3.619939,"marketCap":201671280},{"date":"2024-11-29","current":-3.141297,"twenty":-5.327624,"median":-4.220314,"eighty":-3.127681,"marketCap":217132744},{"date":"2024-12-06","current":-2.830085,"twenty":-5.277482,"median":-3.974826,"eighty":-3.040153,"marketCap":195621141},{"date":"2024-12-13","current":-2.742557,"twenty":-5.237786,"median":-3.781569,"eighty":-2.995417,"marketCap":189571003},{"date":"2024-12-20","current":-1.896449,"twenty":-5.13959,"median":-3.671882,"eighty":-2.96235,"marketCap":131086332},{"date":"2024-12-27","current":-2.207661,"twenty":-5.051841,"median":-3.301766,"eighty":-2.921503,"marketCap":152597935},{"date":"2025-01-03","current":-2.013153,"twenty":-5.003788,"median":-3.151022,"eighty":-2.57139,"marketCap":139153183},{"date":"2025-01-10","current":-1.818646,"twenty":-4.962003,"median":-3.124277,"eighty":-2.236837,"marketCap":125708431},{"date":"2025-01-17","current":-1.954801,"twenty":-4.920218,"median":-3.063494,"eighty":-2.032604,"marketCap":135119757},{"date":"2025-01-24","current":-1.770019,"twenty":-4.870076,"median":-3.005142,"eighty":-1.952856,"marketCap":122347243},{"date":"2025-01-31","current":-1.876998,"twenty":-4.531614,"median":-2.995417,"eighty":-1.91979,"marketCap":129741856},{"date":"2025-02-07","current":-1.701941,"twenty":-4.324777,"median":-2.96624,"eighty":-1.892559,"marketCap":117641580},{"date":"2025-02-14","current":-1.546335,"twenty":-4.251653,"median":-2.932201,"eighty":-1.865328,"marketCap":106885778},{"date":"2025-02-21","current":-1.400454,"twenty":-4.228671,"median":-2.873849,"eighty":-1.840042,"marketCap":96802214},{"date":"2025-02-28","current":-1.351828,"twenty":-4.1451,"median":-2.528598,"eighty":-1.818646,"marketCap":93441026},{"date":"2025-03-07","current":-1.429631,"twenty":-4.03228,"median":-2.256288,"eighty":-1.756403,"marketCap":98818927},{"date":"2025-03-14","current":-1.293475,"twenty":-3.971692,"median":-2.18821,"eighty":-1.542445,"marketCap":89407600},{"date":"2025-03-21","current":-1.244848,"twenty":-3.871407,"median":-2.022879,"eighty":-1.474368,"marketCap":86046412},{"date":"2025-03-28","current":-1.159638,"twenty":-3.794104,"median":-1.954801,"eighty":-1.429631,"marketCap":85693751},{"date":"2025-04-04","current":-1.050066,"twenty":-3.724618,"median":-1.940213,"eighty":-1.381004,"marketCap":77596704},{"date":"2025-04-11","current":-1.059197,"twenty":-3.680923,"median":-1.925625,"eighty":-1.357663,"marketCap":78271458},{"date":"2025-04-17","current":-1.150507,"twenty":-3.672927,"median":-1.896449,"eighty":-1.324596,"marketCap":85018997},{"date":"2025-04-25","current":-1.187031,"twenty":-3.573219,"median":-1.876998,"eighty":-1.28764,"marketCap":87718013},{"date":"2025-05-02","current":-1.150507,"twenty":-3.328025,"median":-1.867273,"eighty":-1.252628,"marketCap":85018997},{"date":"2025-05-09","current":-1.088206,"twenty":-3.166583,"median":-1.847822,"eighty":-1.218825,"marketCap":80415162},{"date":"2025-05-16","current":-0.872124,"twenty":-3.152968,"median":-1.818646,"eighty":-1.187031,"marketCap":81090920},{"date":"2025-05-23","current":-0.872124,"twenty":-3.141297,"median":-1.818646,"eighty":-1.164325,"marketCap":81090920},{"date":"2025-05-30","current":-0.886659,"twenty":-3.134489,"median":-1.784607,"eighty":-1.159638,"marketCap":82442435},{"date":"2025-06-06","current":-0.901194,"twenty":-3.10434,"median":-1.750568,"eighty":-1.150507,"marketCap":83793951},{"date":"2025-06-13","current":-0.930265,"twenty":-3.086835,"median":-1.590099,"eighty":-1.125277,"marketCap":86496981},{"date":"2025-06-20","current":-0.893927,"twenty":-3.063494,"median":-1.522022,"eighty":-1.106495,"marketCap":83118193},{"date":"2025-06-27","current":-0.91573,"twenty":-3.014867,"median":-1.478258,"eighty":-1.095721,"marketCap":85145466},{"date":"2025-07-03","current":-0.930265,"twenty":-3.007087,"median":-1.439356,"eighty":-1.066502,"marketCap":86496981},{"date":"2025-07-11","current":-0.981139,"twenty":-2.997362,"median":-1.429631,"eighty":-1.007303,"marketCap":91227285},{"date":"2025-07-18","current":-1.061084,"twenty":-2.995417,"median":-1.400454,"eighty":-0.995674,"marketCap":98660619},{"date":"2025-07-25","current":-1.075619,"twenty":-2.995417,"median":-1.376141,"eighty":-1.007303,"marketCap":100012135},{"date":"2025-08-01","current":-1.017477,"twenty":-2.979856,"median":-1.361553,"eighty":-1.016024,"marketCap":94606073},{"date":"2025-08-08","current":-1.220973,"twenty":-2.968185,"median":-1.346965,"eighty":-1.017477,"marketCap":113527288},{"date":"2025-08-15","current":-2.492713,"twenty":-2.95846,"median":-1.351828,"eighty":-1.023291,"marketCap":116554252},{"date":"2025-08-22","current":-3.173861,"twenty":-2.979856,"median":-1.366416,"eighty":-1.024745,"marketCap":148403379},{"date":"2025-08-29","current":-3.333278,"twenty":-3.007087,"median":-1.381004,"eighty":-1.030392,"marketCap":155857430},{"date":"2025-09-05","current":-3.376756,"twenty":-3.075164,"median":-1.400454,"eighty":-1.031929,"marketCap":157890353},{"date":"2025-09-12","current":-3.478204,"twenty":-3.149077,"median":-1.429631,"eighty":-1.042845,"marketCap":162633840},{"date":"2025-09-19","current":-3.246323,"twenty":-3.164638,"median":-1.439356,"eighty":-1.052316,"marketCap":151791584},{"date":"2025-09-26","current":-3.043428,"twenty":-3.197049,"median":-1.483121,"eighty":-1.053816,"marketCap":142304610},{"date":"2025-10-03","current":-2.956473,"twenty":-3.173861,"median":-1.53661,"eighty":-1.057045,"marketCap":138238764},{"date":"2025-10-10","current":-2.739085,"twenty":-3.171828,"median":-1.667902,"eighty":-1.060329,"marketCap":128074149},{"date":"2025-10-17","current":-2.82604,"twenty":-3.164638,"median":-1.760293,"eighty":-1.06543,"marketCap":132139995},{"date":"2025-10-24","current":-2.88401,"twenty":-3.171828,"median":-1.808921,"eighty":-1.072703,"marketCap":134850559},{"date":"2025-10-31","current":-2.88401,"twenty":-3.164638,"median":-1.818646,"eighty":-1.075619,"marketCap":134850559},{"date":"2025-11-07","current":-2.603692,"twenty":-3.149077,"median":-1.838097,"eighty":-1.083171,"marketCap":132139995},{"date":"2025-11-14","current":-2.512362,"twenty":-3.141297,"median":-1.857547,"eighty":-1.088206,"marketCap":127504893},{"date":"2025-11-21","current":-2.324271,"twenty":-3.120874,"median":-1.876998,"eighty":-1.092715,"marketCap":117959072},{"date":"2025-11-28","current":-2.539232,"twenty":-3.101423,"median":-1.886723,"eighty":-1.096373,"marketCap":128868582},{"date":"2025-12-05","current":-2.324271,"twenty":-3.090364,"median":-1.896449,"eighty":-1.097379,"marketCap":117959072},{"date":"2025-12-12","current":-3.090071,"twenty":-3.088805,"median":-1.930487,"eighty":-1.097422,"marketCap":156824200},{"date":"2025-12-19","current":-5.88457,"twenty":-3.141297,"median":-1.945076,"eighty":-1.098568,"marketCap":298647825},{"date":"2025-12-26","current":-4.562679,"twenty":-3.173183,"median":-1.969389,"eighty":-1.101167,"marketCap":231560509},{"date":"2026-01-02","current":-3.763034,"twenty":-3.231831,"median":-2.032604,"eighty":-1.10469,"marketCap":190977740},{"date":"2026-01-09","current":-4.308674,"twenty":-3.260816,"median":-2.195782,"eighty":-1.104852,"marketCap":218669512},{"date":"2026-01-16","current":-3.54666,"twenty":-3.333278,"median":-2.236837,"eighty":-1.106495,"marketCap":179996519},{"date":"2026-01-23","current":-4.619124,"twenty":-3.365162,"median":-2.283966,"eighty":-1.112485,"marketCap":234425175},{"date":"2026-01-30","current":-4.496826,"twenty":-3.449218,"median":-2.324271,"eighty":-1.121288,"marketCap":228218399},{"date":"2026-02-06","current":-4.374527,"twenty":-3.488132,"median":-2.337706,"eighty":-1.123114,"marketCap":222011622},{"date":"2026-02-13","current":-4.957797,"twenty":-3.580579,"median":-2.363428,"eighty":-1.131766,"marketCap":251613172},{"date":"2026-02-20","current":-5.305878,"twenty":-3.670837,"median":-2.397337,"eighty":-1.138397,"marketCap":269278613},{"date":"2026-02-27","current":-6.942798,"twenty":-3.770448,"median":-2.418317,"eighty":-1.146855,"marketCap":352353930},{"date":"2026-03-06","current":-5.895163,"twenty":-3.911674,"median":-2.457761,"eighty":-1.150507,"marketCap":352831374},{"date":"2026-03-13","current":-5.794315,"twenty":-4.006508,"median":-2.512362,"eighty":-1.150507,"marketCap":346795534},{"date":"2026-03-20","current":-5.570843,"twenty":-4.127762,"median":-2.533915,"eighty":-1.150507,"marketCap":333420500},{"date":"2026-03-27","current":-5.674598,"twenty":-4.262099,"median":-2.552667,"eighty":-1.150507,"marketCap":339630337},{"date":"2026-04-02","current":-5.546899,"twenty":-4.40275,"median":-2.552667,"eighty":-1.154159,"marketCap":331987461},{"date":"2026-04-10","current":-6.424826,"twenty":-4.493063,"median":-2.591615,"eighty":-1.159638,"marketCap":384532239},{"date":"2026-04-17","current":-7.039457,"twenty":-4.68874,"median":-2.608653,"eighty":-1.159638,"marketCap":421318549},{"date":"2026-04-24","current":-7.199082,"twenty":-4.833617,"median":-2.724593,"eighty":-1.160328,"marketCap":430872257},{"date":"2026-05-01","current":-7.087345,"twenty":-4.902724,"median":-2.742557,"eighty":-1.16195,"marketCap":424184661},{"date":"2026-05-08","current":-9.505662,"twenty":-5.051841,"median":-2.788531,"eighty":-1.165206,"marketCap":568923347},{"date":"2026-05-15","current":-10.251886,"twenty":-5.174172,"median":-2.811548,"eighty":-1.168769,"marketCap":541217592},{"date":"2026-05-22","current":-9.871852,"twenty":-5.232411,"median":-2.842555,"eighty":-1.168769,"marketCap":521154804},{"date":"2026-05-29","current":-10.260935,"twenty":-5.270935,"median":-2.876764,"eighty":-1.172421,"marketCap":541695277},{"date":"2026-06-05","current":-9.871852,"twenty":-5.327624,"median":-2.88401,"eighty":-1.187031,"marketCap":521154804},{"date":"2026-06-12","current":-9.871852,"twenty":-5.377318,"median":-2.898503,"eighty":-1.187031,"marketCap":521154804},{"date":"2026-06-18","current":-12.299862,"twenty":-5.428177,"median":-2.912995,"eighty":-1.187031,"marketCap":649334330},{"date":"2026-06-26","current":-13.731592,"twenty":-5.484622,"median":-2.927339,"eighty":-1.196162,"marketCap":724918221},{"date":"2026-07-02","current":-14.414918,"twenty":-5.570843,"median":-2.937064,"eighty":-1.198568,"marketCap":760992350},{"date":"2026-07-10","current":-14.989779,"twenty":-5.662848,"median":-2.956494,"eighty":-1.212372,"marketCap":791340427},{"date":"2026-07-17","current":-13.644821,"twenty":-5.682623,"median":-2.970966,"eighty":-1.219913,"marketCap":720337379},{"date":"2026-07-24","current":-13.840057,"twenty":-5.734417,"median":-2.990438,"eighty":-1.223039,"marketCap":730644273},{"date":"2026-07-31","current":-13.102499,"twenty":-5.816662,"median":-2.995417,"eighty":-1.223555,"marketCap":691707117},{"date":"2026-08-07","current":-13.912299,"twenty":-5.930387,"median":-3.014443,"eighty":-1.230727,"marketCap":801682322},{"date":"2026-08-14","current":-14.682008,"twenty":-6.54289,"median":-3.029148,"eighty":-1.235508,"marketCap":846036036},{"date":"2026-08-21","current":-16.964547,"twenty":-6.686846,"median":-3.057921,"eighty":-1.239293,"marketCap":977565060},{"date":"2026-08-28","current":-15.010933,"twenty":-6.894117,"median":-3.079659,"eighty":-1.243636,"marketCap":864990000}],"updateTime":1788188297527},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CLYM\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2654043887","title":"Climb Bio is Maintained at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2654043887","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654043887?lang=en_us&edition=fundamental","pubTime":"2026-07-27 21:13","pubTimestamp":1785157980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CLYM/analyst-ratings(END) Dow Jones NewswiresJuly 27, 2026 09:13 ET","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLYM","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654477012","title":"Wedbush Raises Price Target on Climb Bio to $20 From $17, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2654477012","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654477012?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:44","pubTimestamp":1785152683,"startTime":"0","endTime":"0","summary":"Climb Bio (CLYM) has an average rating of buy and mean price target of $21.14, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","BK4139","CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648852678","title":"Climb Bio Director Breanna Maurine Celebi Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2648852678","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648852678?lang=en_us&edition=fundamental","pubTime":"2026-07-02 04:25","pubTimestamp":1782937545,"startTime":"0","endTime":"0","summary":"Climb Bio director Breanna Maurine Celebi files initial beneficial ownership statementClimb Bio filed a Form 3 naming Breanna Maurine Celebi as a director, marking her initial Section 16 insider discl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL2xyx6R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLYM","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648526669","title":"Climb Bio Names Breanna O’reilly to Board After Andrew Levin Resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2648526669","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648526669?lang=en_us&edition=fundamental","pubTime":"2026-07-02 04:18","pubTimestamp":1782937101,"startTime":"0","endTime":"0","summary":"Climb Bio names Breanna O’Reilly to board after Andrew Levin resignsClimb Bio reshaped its board on June 29, 2026, following the resignation of director Andrew Levin, effective immediately.Breanna O'R","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL5tgR0d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLYM","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645889225","title":"Climb Bio Price Target Maintained with a $20.00/share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2645889225","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645889225?lang=en_us&edition=fundamental","pubTime":"2026-06-24 19:00","pubTimestamp":1782298800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CLYM/analyst-ratings(END) Dow Jones NewswiresJune 24, 2026 07:00 ET","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLYM","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645707714","title":"Tango Therapeutics appoints Robert Azelby to board of directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2645707714","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645707714?lang=en_us&edition=fundamental","pubTime":"2026-06-23 04:05","pubTimestamp":1782158746,"startTime":"0","endTime":"0","summary":"Tango Therapeutics appointed biopharmaceutical executive Robert Azelby to its board as it advances PRMT5 inhibitor vopimetostat toward potential late-stage pancreatic cancer development.Azelby previously led Eliem Therapeutics as CEO, ran Alder BioPharmaceuticals through its sale to H. Lundbeck, served as Juno Therapeutics’ chief commercial officer.He also spent 15 years at Amgen, ending as vice president and general manager of oncology overseeing a $6 billion portfolio.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDLc0HXqp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFXG1179.USD","LU0114720955.EUR","LU0456855351.SGD","NDAQ","LU1093756168.USD","LU2125154778.USD","TNGX","IE00B4R5TH58.HKD","LU1868837136.USD","LU0985481810.HKD","LU1093756325.SGD","LU1989771016.USD","LU0306806265.USD","LU1291159041.SGD","LU1323610961.USD","BK4566","BK4599","CLYM","IE00BSNM7G36.USD","BK4139","LU1718418525.SGD","AMGN","LU1868837300.USD","LU2125154935.USD","LU2360032135.SGD","LU2210149790.SGD","IE00BFTCPJ56.SGD","LU2089984988.USD","IE0002141913.USD","SG9999014005.SGD","IE00BN0W2T93.GBP","LU1585245621.USD","BK4534","BMY","LU0321505439.SGD","LU1983299246.USD","LU0225284248.USD","LU0109394709.USD","BK4112","IE00B2B36J28.USD","LU1670711040.USD","BK4559","LU0432979614.USD","BK4581","IE00BGHQF748.EUR","LU0314104364.USD","LU1061106388.HKD","BK4007","BK4539","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643589213","title":"BRIEF-Climb Bio - Enters Open Market Sale Agreement With Jefferies - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2643589213","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643589213?lang=en_us&edition=fundamental","pubTime":"2026-06-13 05:01","pubTimestamp":1781298063,"startTime":"0","endTime":"0","summary":"BRIEF-Climb Bio - Enters Open Market Sale Agreement With Jefferies - SEC FilingJune 12  - Climb Bio Inc CLYM.O:CLIMB BIO - ENTERS OPEN MARKET SALE AGREEMENT WITH JEFFERIES - SEC FILINGCLIMB BIO - MAY OFFER AND SELL UP TO $100 MILLION OF COMMON STOCK - SEC FILINGSource text: [ID:n0001193125-26-269567]Further company coverage: CLYM.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nFWN42K0K8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLYM","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643428218","title":"Climb Bio enters Jefferies ATM equity distribution agreement for up to $100 million stock sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2643428218","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643428218?lang=en_us&edition=fundamental","pubTime":"2026-06-13 04:37","pubTimestamp":1781296641,"startTime":"0","endTime":"0","summary":"Climb Bio entered an at-the-market equity distribution agreement with Jefferies for up to USD 100 million of common stock.Jefferies will act as sales agent with up to 3% commission on shares sold.The prior ATM program with Oppenheimer was terminated effective June 11, 2026; no shares were sold under that program.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Climb Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL1v9n1L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CLYM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643185732","title":"Climb Bio - Enters Open Market Sale Agreement With Jefferies Dated June 12, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2643185732","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643185732?lang=en_us&edition=fundamental","pubTime":"2026-06-13 04:24","pubTimestamp":1781295874,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nFWN42K0P3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642293126","title":"Analysts Conflicted on These Healthcare Names: United Therapeutics (UTHR), DENTSPLY SIRONA (XRAY) and Climb Bio (CLYM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642293126","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642293126?lang=en_us&edition=fundamental","pubTime":"2026-06-12 20:50","pubTimestamp":1781268613,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on United Therapeutics (UTHR), DENTSPLY SIRONA (XRAY)...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-united-therapeutics-uthr-dentsply-sirona-xray-and-climb-bio-clym-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-united-therapeutics-uthr-dentsply-sirona-xray-and-climb-bio-clym-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1571399168.USD","BK4198","HCSG","LU1699723380.USD","BK4532","BK4588","CLYM","XBI","BK4137","UTHR","LABU","BK4539","BK4139","XLV","BK4581","BK4585","LU0029874061.USD","XRAY","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642235488","title":"Climb Bio price target raised to $20 from $19 at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2642235488","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642235488?lang=en_us&edition=fundamental","pubTime":"2026-06-12 00:26","pubTimestamp":1781195203,"startTime":"0","endTime":"0","summary":"BTIG analyst Julian Harrison raised the firm’s price target on Climb Bio (CLYM) to $20 from $19 and keeps a Buy rating on the shares. Budoprutug, a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/climb-bio-price-target-raised-to-20-from-19-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/climb-bio-price-target-raised-to-20-from-19-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLYM","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642323568","title":"Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR) and Climb Bio (CLYM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642323568","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642323568?lang=en_us&edition=fundamental","pubTime":"2026-06-12 00:00","pubTimestamp":1781193648,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Schrodinger (SDGR) and Climb Bio (CLYM) with bullish...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-schrodinger-sdgr-and-climb-bio-clym-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-schrodinger-sdgr-and-climb-bio-clym-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","HCSG","LABU","LU0029874061.USD","LU0128526141.USD","XLV","BK4139","BK4585","XBI","BK4137","CLYM","SDGR","BK4581","BK4588","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642233444","title":"Climb Bio Is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2642233444","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642233444?lang=en_us&edition=fundamental","pubTime":"2026-06-11 23:52","pubTimestamp":1781193120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CLYM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 11, 2026 11:52 ET (15:52 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLYM","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642210286","title":"Climb Bio reports initial Phase 1b data showing platelet responses for budoprutug in immune thrombocytopenia trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2642210286","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642210286?lang=en_us&edition=fundamental","pubTime":"2026-06-11 19:02","pubTimestamp":1781175746,"startTime":"0","endTime":"0","summary":"Climb Bio presented initial Phase 1b data at EHA Congress 2026 for budoprutug in primary immune thrombocytopenia.Early results showed favorable safety and tolerability, with no serious safety signals reported in the cohorts disclosed.The study showed clear biological activity, with B-cell suppression and meaningful, durable platelet responses in heavily pretreated patients.Responses were observed in some patients previously treated with rituximab, supporting potential differentiation in a hard-to-treat population.Enrollment continues in the high-dose cohort, with additional data expected by year-end 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDLbmtmjp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLYM","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642861322","title":"Climb Bio - Announces Initial Phase 1B Data for Budoprutug in Immune Thrombocytopenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2642861322","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642861322?lang=en_us&edition=fundamental","pubTime":"2026-06-11 19:00","pubTimestamp":1781175651,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nFWN42J01I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLYM","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642286164","title":"Climb Bio - Enrollment Ongoing in 1000 Mg Cohort With Data Expected by Year-End 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2642286164","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642286164?lang=en_us&edition=fundamental","pubTime":"2026-06-11 19:00","pubTimestamp":1781175651,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nFWN42J01I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642431571","title":"Climb Bio sets 5,216,105-share cap under 2021 equity incentive plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2642431571","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642431571?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:08","pubTimestamp":1780949321,"startTime":"0","endTime":"0","summary":"Climb Bio adopted a 2021 Equity Incentive Plan, effective immediately before its IPO date, replacing the 2019 plan for new grants.Share pool set at 5,216,105 shares, including 2,558,790 new shares, with up to 2,657,315 shares recycled from the prior plan.Automatic annual increases set at 5% of shares outstanding from Jan. 1, 2022 through Jan. 1, 2026, subject to board reduction.Non-employee director pay capped at USD 750,000 per year, rising to USD 1 million for a director first appointed or elected that year.Options or SARs carry a maximum 10-year term, with post-termination exercise windows of 3 months, 12 months for disability, 18 months for death.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Climb Bio Inc. published the original ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL9jNgdG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLYM","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641489520","title":"Climb Bio initiated with a Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2641489520","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641489520?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:16","pubTimestamp":1780917389,"startTime":"0","endTime":"0","summary":"Guggenheim initiated coverage of Climb Bio (CLYM) with a Buy rating and $35 price target. Lead asset budoprutug is delivering deep B-cell depletion...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/climb-bio-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/climb-bio-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","CLYM","DBB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641483029","title":"Guggenheim Initiates Climb Bio at Buy With $35 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2641483029","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641483029?lang=en_us&edition=fundamental","pubTime":"2026-06-08 18:19","pubTimestamp":1780913990,"startTime":"0","endTime":"0","summary":"Climb Bio (CLYM) has an average rating of buy and mean price target of $19.77, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","BK4139","CLYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641488412","title":"Climb Bio Price Target Maintained With a $19.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2641488412","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641488412?lang=en_us&edition=fundamental","pubTime":"2026-06-08 17:49","pubTimestamp":1780912140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CLYM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 08, 2026 05:49 ET (09:49 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLYM","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":105,"code":"91000000","status":"200"}]}}